Injecting Traditional Scientific Exchange with New Life

October 13, 2020

Female medical affairs leaders speak out with unique perspectives on how MSLs can provide greater value to opinion leaders.

Commercial Sustainability of Pharmaceutical Innovations for Pandemics

September 30, 2020

Assessing the landscape of the pharma industry’s readiness for future pandemics by looking at past pandemics, funding and revenue, and sustainability.

Manage Risk Effectively to Improve the Value of Your Alliance

September 29, 2020

In this article, Eli Lilly & Co. examines risk management in the context of partnerships with other companies.

New Standards for First-to-Launch Players

September 14, 2020

While COVID-19 has shifted some of the rules, research reveals that practice changes were already afoot for market newcomers.

Commercializing an Orphan Drug: Why “Just” Serving a High Unmet Medical Need Won’t Do the Job

September 08, 2020

Looking at four building blocks of success, Wolfram Lux and Simone Seiter investigate what it takes to win and be successful when commercializing an orphan drug

Don’t Waste A Crisis: How Paratek is Navigating the Business Implications of the COVID-19 Pandemic

August 31, 2020

A look at how pharmaceutical company, Paratek is navigating the launch of a new antibiotic during the COVID-19 pandemic.